About Penta
Who we are
Diversity and Inclusion
Our Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
PD-1+ CD4 T cells are associated with HIV reservoir size and impaired function of T follicular helper cells in children and young adults on long-term viral control
Standardising neonatal and pediatric anitibiotic clinical trial design and conduct: the PENTA-ID network review
Season’s Greetings from Penta!
Data from ODYSSEY are used by ViiV Healthcare to file FDA and EMA submissions for the first-ever dispersible formulation of dolutegravir for children living with HIV
Role of Magnetic Resonance Imaging and cranial ultrasonography in congenital Cytomegalovirus infection
Human Rights Day
Picturing Health launches new video on adolescents with HIV
World AIDS Day 2019: Communities make the difference
Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays
Universal Children’s Day
European Antibiotic Awareness Day
Penta’s Davide Bilardi wins award for outstanding research work
Analysing small groups within clinical trials, while borrowing information from larger groups
Yellow Fever virus reemergence and spread in southeast Brazil, 2016-2019
Factors predicting the severity of dengue in patients with warning signs in Rio de Janeiro, Brazil (1986–2012)
EPIICAL data on Journal of AIDS: treat early, suppress fast!
Reduced time to suppression among neonates with HIV initiating antiretroviral therapy within 7 days of age
Time to HIV suppression in perinatally infected infants depends on the viral load and CD4 T-cell percentage at the start of treatment